These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33256542)

  • 1. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
    Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
    Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.
    Sakamoto LH; DE Camargo B; Cajaiba M; Soares FA; Vettore AL
    Pediatr Res; 2010 Apr; 67(4):387-93. PubMed ID: 20032811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
    Gödeke J; Luxenburger E; Trippel F; Becker K; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
    Hepatol Int; 2016 Mar; 10(2):370-6. PubMed ID: 26646663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
    Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
    Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
    Li X; Kogner P; Sandstedt B; Haas OA; Ekström TJ
    Int J Cancer; 1998 Jan; 75(2):176-80. PubMed ID: 9462704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
    Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
    BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
    Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
    Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
    Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
    J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
    Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
    Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
    Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
    Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.
    Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z
    Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
    Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
    Xu J; Capezzone M; Xu X; Hershman JM
    Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
    Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
    Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
    Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
    Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.
    Roberti A; Fernández AF; Fraga MF
    Mol Metab; 2021 Mar; 45():101165. PubMed ID: 33453420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
    Xu J; Hershman JM
    Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.